286 related articles for article (PubMed ID: 17318870)
1. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
Green M; Webber SA
Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
[No Abstract] [Full Text] [Related]
2. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) early-antigen antibodies and EBV DNA load in blood, in posttransplantation lymphoproliferative disease.
Leruez-Ville M; Talbotec C; Iserin F; Salomon R; Lacaille F; Rouzioux C
J Infect Dis; 2004 Oct; 190(8):1524-5; author reply 1525-6. PubMed ID: 15378447
[No Abstract] [Full Text] [Related]
4. [Clinical significance of Epstein-Barr virus load].
Dehée A
Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():28-33. PubMed ID: 11675291
[No Abstract] [Full Text] [Related]
5. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr viral load before a liver transplant in children with chronic liver disease.
Shakibazad N; Honar N; Dehghani SM; Alborzi A
Exp Clin Transplant; 2014 Dec; 12(6):534-8. PubMed ID: 25489804
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant lymphoproliferative diseases.
Gross TG; Savoldo B; Punnett A
Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and posttransplant lymphoproliferative disease.
Holmes R
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
[No Abstract] [Full Text] [Related]
10. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus.
Yilmaz A; Hazar V; Akçam M; Inanç-Gürer E; Ceken K; Artan R
Turk J Pediatr; 2007; 49(4):434-6. PubMed ID: 18246749
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of Epstein-Barr virus.
Häusler M; Scheithauer S; Ritter K; Kleines M
Expert Rev Mol Diagn; 2003 Jan; 3(1):81-92. PubMed ID: 12528366
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
Petrovic LM
Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
[No Abstract] [Full Text] [Related]
13. Posttransplantation lymphoproliferative disorders.
Andreone P; Gramenzi A; Lorenzini S; Biselli M; Cursaro C; Pileri S; Bernardi M
Arch Intern Med; 2003 Sep; 163(17):1997-2004. PubMed ID: 14504111
[TBL] [Abstract][Full Text] [Related]
14. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
[No Abstract] [Full Text] [Related]
15. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
[TBL] [Abstract][Full Text] [Related]
16. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus.
Hierro L; Díez-Dorado R; Díaz C; De la Vega A; Frauca E; Camarena C; Muñoz-Bartolo G; González de Zárate A; López Santamaría M; Jara P
Liver Transpl; 2008 Aug; 14(8):1185-93. PubMed ID: 18668670
[TBL] [Abstract][Full Text] [Related]
19. Loads, lungs, and lymphoproliferative disorders: role of Epstein-Barr virus and limitations of what we know.
Green M; Michaels MG
Transpl Infect Dis; 2010 Aug; 12(4):281-3. PubMed ID: 20727122
[No Abstract] [Full Text] [Related]
20. [Posttransplant lymphoproliferative disorder].
Oike F; Egawa H; Haga H; Kudo T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():639-46. PubMed ID: 16615551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
